Plethora's European Phase III premature ejaculation study meets … – Pharmaceutical Business Review
Nov.07, 2008 in
News
Plethora's European Phase III premature ejaculation study meets ... Pharmaceutical Business Review - ... (p<0.0001) and a six point difference between PSD502 and placebo in the index of premature ejaculation (IPE) domain for sexual satisfaction (p<0.0001), ... |

Leave a Reply